At-home sleep apnea care

How Daybreak's At-Home Testing Works

Instead of spending a night in a sleep lab, patients receive a small wireless finger monitor shipped to their home. They wear it for several nights while sleeping normally. The device measures oxygen levels and breathing patterns throughout the night. A physician then reviews the data remotely and provides results. USA Today notes that if sleep apnea is confirmed, patients can move directly to treatment without scheduling office visits.

Qualifying patients receive a custom oral appliance — a mandibular advancement device that gently moves the lower jaw forward to keep airways open. Patients make dental impressions at home using simple putty and 3D scanning. State-licensed dentists and sleep physicians oversee the process remotely. Treatment typically takes a median of 42 days from test to fitted device.

1 source

Strong Clinical Results in Early Research

Cedars-Sinai Medical Center published a peer-reviewed study in the *American Journal of Clinical and Medical Research* evaluating 185 patients using Daybreak's fully virtual pathway. The researchers found that 83% met treatment success criteria. Among patients with mild sleep apnea, 88% reduced their breathing interruptions below the threshold that requires treatment, showing the approach works for real patients.

A separate 200-patient case study highlighted by SleepWorld Magazine in June 2026 demonstrated clinical viability of the telehealth-guided therapy. Daybreak reports a 90% treatment retention rate at 2.5 years and a 94% reduction in snoring. These numbers suggest patients stay with the treatment long-term, unlike traditional CPAP machines which have notoriously poor compliance.

Insurance Coverage and Cost Considerations

The at-home test costs $129.95 to $159.95, often discounted from the regular $159.95 price. Since Daybreak's oral appliance is an FDA-cleared Class II medical device, it qualifies for medical insurance coverage and HSA or FSA account eligibility. Out-of-pocket costs for the device itself typically range from $500 to $1,100, depending on your insurance plan and coverage level.

Questions About Diagnostic Accuracy

While Daybreak's results look promising, some concerns have surfaced. An FDA adverse event report from July 2026 flagged discrepancies between Daybreak's at-home test results and independent sleep studies. In one case, a patient's Daybreak follow-up test showed zero breathing interruptions, but an independent lab recorded 11.3 interruptions per hour. This raises questions about whether at-home testing catches all cases.

Some online patient communities also report that Daybreak sales representatives apply pressure to purchase treatment options during initial diagnostic calls, even when findings are borderline. The company's direct-to-consumer model eliminates traditional medical gatekeeping but shifts responsibility to patients to navigate upselling tactics. Independent verification of test accuracy remains limited compared to full overnight polysomnography in a controlled sleep laboratory.